Regulation of human IL-18 gene expression: interaction of PU.1 with GC-box binding protein is involved in human IL-18 expression in myeloid cells

被引:21
作者
Koyama, N [1 ]
Hoelzer, D [1 ]
Ottmann, OG [1 ]
机构
[1] Johann Wolfgang Goethe Univ Hosp, Div Hematol, D-60590 Frankfurt, Germany
关键词
IL-18; sodium butyrate; PU.1; gene regulation; myeloid cells; GC-rich region;
D O I
10.1002/eji.200324420
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-18 (IL-18) is a pro-inflammatory cytokine which participates in host defense against a variety of infections as well as in chronic inflammation including autoimmune diseases. However, little is known about human IL-18 regulation at the gene level. We have previously demonstrated that sodium butyrate, a bacterial fermentation product, induces IL-18 production via the proximal region of the promoter. In this study we investigated the molecular mechanisms for basal and sodium butyrate-induced expression of IL-18 in human myeloid cells. Two regulatory regions, a consensus binding site for PUA and a GC-rich region, are required for basal IL-18 promoter activity in human myeloid cells. PU.1 bound to the PU.1 consensus binding site in electrophoretic mobility shift assays, and overexpression of PU.1 led to activation of the IL-1 8 promoter through this site. Mutation analysis revealed that the GC-rich region, but not PU.1 site, participates in sodium butyrate-induced transactivation. Furthermore, DNA pull-down experiments and the critical spacing of the two binding sites suggest that formation of a protein complex involving both cis elements and the respective binding proteins might be crucial for human IL-1 8 expression.
引用
收藏
页码:817 / 826
页数:10
相关论文
共 45 条
[1]   The role of IL-18 in innate immunity [J].
Akira, S .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :59-63
[2]  
Baudler M, 1997, J BIOL CHEM, V272, P131
[3]  
BOFFA LC, 1978, J BIOL CHEM, V253, P3364
[4]   Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation [J].
Boosalis, MS ;
Bandyopadhyay, R ;
Bresnick, EH ;
Pace, BS ;
Van DeMark, K ;
Zhang, BH ;
Faller, DV ;
Perrine, SP .
BLOOD, 2001, 97 (10) :3259-3267
[5]   Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis [J].
Coughlin, CM ;
Salhany, KE ;
Wysocka, M ;
Aruga, E ;
Kurzawa, H ;
Chang, AE ;
Hunter, CA ;
Fox, JC ;
Trinchieri, G ;
Lee, WMF .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (06) :1441-1452
[6]   Interleukin-18 [J].
Dinarello, CA .
METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1999, 19 (01) :121-132
[7]   THE PROMOTER-SPECIFIC TRANSCRIPTION FACTOR-SP1 BINDS TO UPSTREAM SEQUENCES IN THE SV40 EARLY PROMOTER [J].
DYNAN, WS ;
TJIAN, R .
CELL, 1983, 35 (01) :79-87
[8]   Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation [J].
Giedraitis, V ;
He, B ;
Huang, WX ;
Hillert, J .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 112 (1-2) :146-152
[9]   The MHC-specific enhanceosome and its role in MHC class I and β2-microglobulin gene transactivation [J].
Gobin, SJP ;
van Zutphen, M ;
Westerheide, SD ;
Boss, JM ;
van den Elsen, PJ .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :5175-5184
[10]   Interleukin-18 [J].
Gracie, JA ;
Robertson, SE ;
McInnes, IB .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 73 (02) :213-224